These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36930691)

  • 1. CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort Study.
    Gedebjerg A; Bjerre M; Kjaergaard AD; Nielsen JS; Rungby J; Brandslund I; Maeng M; Beck-Nielsen H; Vaag A; Sørensen HT; Hansen TK; Thomsen RW
    Diabetes Care; 2023 May; 46(5):1037-1045. PubMed ID: 36930691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of high-sensitivity CRP increases during circadian rhythm for prediction of long-term cardiovascular events in patients with stable coronary artery disease].
    Koç M; Sahin DY; Uysal OK; Karaarslan O; Dönmez E; Abalı G; Batur MK
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):568-75. PubMed ID: 21983767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
    Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
    J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.
    Wang Z; Tang J; Shi Q; Fang L; Liu N; Zhang J
    Front Endocrinol (Lausanne); 2024; 15():1392859. PubMed ID: 38812817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of high sensitivity C-reactive protein in three-vessel disease patients with and without type 2 diabetes.
    Guo L; Lv H; Wang J; Zhang B; Zhu Y; Zhang X; Zhu H; Zhou X; Xia Y
    Cardiovasc Diabetol; 2023 Apr; 22(1):91. PubMed ID: 37081535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study.
    Nafari A; Mohammadifard N; Haghighatdoost F; Nasirian S; Najafian J; Sadeghi M; Roohafza H; Sarrafzadegan N
    BMC Cardiovasc Disord; 2022 May; 22(1):241. PubMed ID: 35614388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Salles GF
    J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus.
    Matsumoto K; Sera Y; Abe Y; Ueki Y; Tominaga T; Miyake S
    Atherosclerosis; 2003 Aug; 169(2):317-21. PubMed ID: 12921984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study.
    Yan ST; Sun J; Gu ZY; Miao XY; Ma LC; Sun BR; Fu XM; Liu HZ; Yang G; Fang FS; Li H
    Cardiovasc Diabetol; 2022 Oct; 21(1):201. PubMed ID: 36192784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study.
    Gedebjerg A; Bjerre M; Kjaergaard AD; Steffensen R; Nielsen JS; Rungby J; Friborg SG; Brandslund I; Thiel S; Beck-Nielsen H; Sørensen HT; Hansen TK; Thomsen RW
    Diabetes Care; 2020 Sep; 43(9):2190-2198. PubMed ID: 32616614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
    Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
    J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes.
    Hoes LLF; Riksen NP; Geleijnse JM; de Groot MCH; T van der Schouw Y; Visseren FLJ; Koopal C;
    Diabetes Res Clin Pract; 2024 Jul; 213():111727. PubMed ID: 38848966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study.
    Thomsen RW; Knudsen JS; Kahlert J; Baggesen LM; Lajer M; Holmgaard PH; Vedin O; Ustyugova A; Sørensen HT
    J Am Heart Assoc; 2021 Jun; 10(11):e019356. PubMed ID: 34032121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
    Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study.
    Zhang Y; Jin JL; Cao YX; Zhang HW; Guo YL; Wu NQ; Zhu CG; Gao Y; Hua Q; Li YF; Xu RX; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):111. PubMed ID: 32646432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.